Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1373-1382

  Thinwa, Josephine ^a   Segovia, Jesus A ^a,b   Bose, Santanu ^a,b,c   Dube, Peter H ^a,b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA1 INTEGRIN; CRYOPYRIN; FOCAL ADHESION KINASE; INFLAMMASOME; INTERLEUKIN 18; INVASIN; PROTEIN YOPH; RAC1 PROTEIN; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN E;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FOCAL ADHESION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ADHESINS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TOXINS; CACO-2 CELLS; CARRIER PROTEINS; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; INFLAMMASOMES; INTEGRIN ALPHA5BETA1; INTERLEUKIN-18; INTESTINAL MUCOSA; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASES; SIGNAL TRANSDUCTION; VIRULENCE FACTORS; YERSINIA ENTEROCOLITICA;

EID: 84906075102     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400145     Document Type: Article

References (53)

1. Kamada, N., S. U. Seo, G. Y. Chen, and G. Núñez. 2013. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13: 321-335.
2. Winter, S. E., A. M. Keestra, R. M. Tsolis, and A. J. Bäumler. 2010. The blessings and curses of intestinal inflammation. Cell Host Microbe 8: 36-43.
3. Abreu, M. T., P. Vora, E. Faure, L. S. Thomas, E. T. Arnold, and M. Arditi. 2001. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167: 1609-1616.
4. Gross, O., C. J. Thomas, G. Guarda, and J. Tschopp. 2011. The inflammasome: an integrated view. Immunol. Rev. 243: 136-151.
5. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
6. Martinon, F., and J. Tschopp. 2007. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14: 10-22.
7. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
8. von Moltke, J., J. S. Ayres, E. M. Kofoed, J. Chavarría-Smith, and R. E. Vance. 2013. Recognition of bacteria by inflammasomes. Annu. Rev. Immunol. 31: 73-106.
9. Allen, I. C., E. M. TeKippe, R. M. Woodford, J. M. Uronis, E. K. Holl, A. B. Rogers, H. H. Herfarth, C. Jobin, and J. P. Ting. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitisassociated cancer. J. Exp. Med. 207: 1045-1056.
10. Hirota, S. A., J. Ng, A. Lueng, M. Khajah, K. Parhar, Y. Li, V. Lam, M. S. Potentier, K. Ng, M. Bawa, et al. 2011. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17: 1359-1372.
11. Zaki, M. H., K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T. D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391.
12. Isberg, R. R. 1996. Uptake of enteropathogenic Yersinia by mammalian cells. Curr. Top. Microbiol. Immunol. 209: 1-24.
13. Bottone, E. J. 1997. Yersinia enterocolitica: the charisma continues. Clin. Microbiol. Rev. 10: 257-276.
14. Dube, P. 2009. Interaction of Yersinia with the gut: mechanisms of pathogenesis and immune evasion. Curr. Top. Microbiol. Immunol. 337: 61-91.
15. Isberg, R. R., and S. Falkow. 1985. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317: 262-264.
16. Miller, V. L., and S. Falkow. 1988. Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect. Immun. 56: 1242-1248.
17. Clark, M. A., B. H. Hirst, and M. A. Jepson. 1998. M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66: 1237-1243.
18. Cornelis, G. R. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3: 742-752.
19. Viboud, G. I., and J. B. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59: 69-89.
20. Büttner, D. 2012. Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant-and animal-pathogenic bacteria. Microbiol. Mol. Biol. Rev. 76: 262-310.
21. Auerbuch, V., D. T. Golenbock, and R. R. Isberg. 2009. Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog. 5: e1000686.
22. Bliska, J. B., X. Wang, G. I. Viboud, and I. E. Brodsky. 2013. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cell. Microbiol. 15: 1622-1631.
23. Brodsky, I. E., N. W. Palm, S. Sadanand, M. B. Ryndak, F. S. Sutterwala, R. A. Flavell, J. B. Bliska, and R. Medzhitov. 2010. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7: 376-387.
24. LaRock, C. N., and B. T. Cookson. 2012. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 12: 799-805.
25. Black, D. S., and J. B. Bliska. 1997. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 16: 2730-2744.
26. Bruce-Staskal, P. J., C. L. Weidow, J. J. Gibson, and A. H. Bouton. 2002. Cas, Fak and Pyk2 function in diverse signaling cascades to promote Yersinia uptake. J. Cell Sci. 115: 2689-2700.
27. Persson, C., N. Carballeira, H. Wolf-Watz, and M. Fällman. 1997. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 16: 2307-2318.
28. Weidow, C. L., D. S. Black, J. B. Bliska, and A. H. Bouton. 2000. CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells. Cell. Microbiol. 2: 549-560.
29. Alrutz, M. A., and R. R. Isberg. 1998. Involvement of focal adhesion kinase in invasin-mediated uptake. Proc. Natl. Acad. Sci. USA 95: 13658-13663.
30. Rolán, H. G., E. A. Durand, and J. Mecsas. 2013. Identifying Yersinia YopHtargeted signal transduction pathways that impair neutrophil responses during in vivo murine infection. Cell Host Microbe 14: 306-317.
31. Black, D. S., and J. B. Bliska. 2000. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37: 515-527.
32. Bose, R., J. Thinwa, P. Chaparro, Y. Zhong, S. Bose, G. Zhong, and P. H. Dube. 2012. Mitogen-activated protein kinase-dependent interleukin-1a intracrine signaling is modulated by YopP during Yersinia enterocolitica infection. Infect. Immun. 80: 289-297.
33. Schotte, P., G. Denecker, A. Van Den Broeke, P. Vandenabeele, G. R. Cornelis, and R. Beyaert. 2004. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J. Biol. Chem. 279: 25134-25142.
34. Shin, H., and G. R. Cornelis. 2007. Type III secretion translocation pores of Yersinia enterocolitica trigger maturation and release of pro-inflammatory IL-1beta. Cell. Microbiol. 9: 2893-2902.
35. Zheng, Y., S. Lilo, I. E. Brodsky, Y. Zhang, R. Medzhitov, K. B. Marcu, and J. B. Bliska. 2011. A Yersinia effector with enhanced inhibitory activity on the NF-kB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog. 7: e1002026.
36. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
37. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160: 299-307.
38. Meng, X., M. Leman, and Y. Xiang. 2007. Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 358: 211-220.
39. Jung, H. C., L. Eckmann, S. K. Yang, A. Panja, J. Fierer, E. Morzycka-Wroblewska, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95: 55-65.
40. Pétrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14: 1583-1589.
41. Grassl, G. A., E. Bohn, Y. Müller, O. T. Bühler, and I. B. Autenrieth. 2003. Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int. J. Med. Microbiol. 293: 41-54.
42. Kühn, K., and J. Eble. 1994. The structural bases of integrin-ligand interactions. Trends Cell Biol. 4: 256-261.
43. Isberg, R. R., and J. M. Leong. 1990. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60: 861-871.
44. Leong, J. M., P. E. Morrissey, A. Marra, and R. R. Isberg. 1995. An aspartate residue of the Yersinia pseudotuberculosis invasin protein that is critical for integrin binding. EMBO J. 14: 422-431.
45. Hamburger, Z. A., M. S. Brown, R. R. Isberg, and P. J. Bjorkman. 1999. Crystal structure of invasin: a bacterial integrin-binding protein. Science 286: 291-295.
46. Gao, Y., J. B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101: 7618-7623.
47. Mejía, E., J. B. Bliska, and G. I. Viboud. 2008. Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog. 4: e3.
48. Saltman, L. H., Y. Lu, E. M. Zaharias, and R. R. Isberg. 1996. A region of the Yersinia pseudotuberculosis invasin protein that contributes to high affinity binding to integrin receptors. J. Biol. Chem. 271: 23438-23444.
49. Jun, H. K., S. H. Lee, H. R. Lee, and B. K. Choi. 2012. Integrin a5b1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. Immunity 36: 755-768.
50. Davis, B. K., H. Wen, and J. P. Ting. 2011. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29: 707-735.
51. Bergsbaken, T., and B. T. Cookson. 2007. Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3: e161.
52. Funda, D. P., L. Tucková, M. A. Farré, T. Iwase, I. Moro, and H. Tlaskalová-Hogenová. 2001. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect. Immun. 69: 3772-3781.
53. Izmailyan, R., J. C. Hsao, C. S. Chung, C. H. Chen, P. W. Hsu, C. L. Liao, and W. Chang. 2012. Integrin b1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. J. Virol. 86: 6677-6687.